latest news releases from the newsroom
Capital Research Group, Inc
TheSUBWAY.com Announces Its Stock Market Standouts List for Tuesday, June 22, 2004: APBH, CIEN, RFMD, LVLT
WESTON, Fla., June 22, 2004 (PRIMEZONE) -- TheSUBWAY.com names the following stocks to its Stock Market Standouts List: Americana Publishing, Inc. (OTCBB:APBH), CIENA Corporation (Nasdaq:CIEN), RF Micro Devices, Inc. (Nasdaq:RFMD), Level 3 Communications (Nasdaq:LVLT).
ViroPharma Incorporated Decides to Terminate Exchange Offer
EXTON, Pa., June 22, 2004 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM), a pharmaceutical company focused on developing and commercializing products that address serious diseases treated by physician specialists and in hospital settings, including cytomegalovirus (CMV) and hepatitis C (HCV), today announced that its exchange offer for up to $99,122,500 aggregate principal amount of its new 6% Convertible Senior Plus Cash Notes(SM) due 2009 for up to all of the $127,900,000 aggregate principal amount of its currently outstanding 6% Convertible Subordinated Notes, expired in accordance with its terms on June 21, 2004.
Kingsley Coach, Inc.
Kingsley Coach Reports Record Backlog
ANDOVER, Minn., June 22, 2004 (PRIMEZONE) -- Kingsley Coach, Inc. (OTCBB:KNGS) announced today that it has attained a record backlog as of June 21, 2004. The Company has a current backlog of sixteen (16) coaches, as compared to thirteen (13) coaches at December 31, 2003, and eight (8) coaches at the same time a year ago.
Power3 Medical Products
Power3 Early Detection Breast Cancer Screening Test to Enter Clinical Validation Trials
THE WOODLANDS, Texas, June 22, 2004 (PRIMEZONE) -- Power3 Medical Products, Inc. (OTCBB:PWRM) announced today the Company will conduct clinical evaluations on its early detection breast cancer NAF Test (nipple aspirate fluid) this summer. The Company's NAF Test, for the detection, diagnosis, and monitoring of breast cancer, utilizes fluids from the breast called nipple aspirates to identify groups of breast cancer proteins. Through proteomic analysis of this breast ductal fluid, the Company believes it has engineered the first test of its type that detects breast cancer years earlier than current technology.
Tele2 AB Share Reclassification
STOCKHOLM, Sweden and NEW YORK, June 22, 2004 (PRIMEZONE) -- Tele2 AB, ("Tele2"), (Nasdaq:TLTOA) (Nasdaq:TLTOB) (Stockholmsborsen: TEL2A and TEL2B), the leading alternative pan-European telecommunications company, today announced that holders of 6,173,141 class A shares have registered to reclassify their class A shares into class B shares. The reclassification is made in accordance with the resolution passed at the Annual General Meeting on May 12, 2004. The number of class A shares following the reclassification is 15,516,663 and the number of class B shares is 132,043,512. The total number of outstanding shares remains unchanged at 147,560,175.
Humana Trans Services Holding Corp./HTSC Receives Financing Commitment
HANOVER, Md., June 22, 2004 (PRIMEZONE) -- Humana Trans Services Holding Corporation (OTCBB:HTSC) (http://www.humanaservices.com), announced today that it has signed a definitive agreement for a $10,000,000.00 financing. The proceeds of the financing will be used to facilitate the company's expansion plans, funding the proposed acquisitions and for working capital. This funding will also afford the company the ability to seek larger acquisitions and expand its growth strategy.